1. Barnd DL, Lan MS, Metzgar RS, Finn OJ (1989) Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci USA 86: 7159
2. Burchell J, Gendler S, Taylor-Papadimitriou J, Girling A, Lewis A, Millis R, Lamport D (1987) Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res 47: 5476
3. Codington JF, Frim DM (1983) Cell-surface macromolecular and morphological changes related to allotransplantability in the TA3 tumor. In: Manson LA (ed) Biomembranes, vol 2. Plenum, New York, p 207
4. Codington JF, Bhavanandan VP, Bloch KJ, Nikrui N, Ellard JV, Wang PS, Jeanloz RW (1984) Antibody to epiglycanin and radioimmunoassay to detect epiglycanin-related glycoproteins in body fluids of cancer patients. JNCI 73: 1029
5. Fung PS, Longenecker BM (1991) Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-Ha). Cancer Res 51: 1170